DCGCN:双通道图形卷积基于网络的药物向相互作用预测方法与3D分子结构
Chang Sun1,2, Yuxin Shen1,2, Min Xu1,2
1College of Artificial Intelligence, Tianjin Normal University, Tianjin 300387, China.
Journal of chemical information and modeling
|July 3, 2025
概括
这项研究介绍了DCGCN,这是一种利用3D分子结构的新型药物向相互作用 (DTI) 预测方法. 通过捕捉超出传统的2D或线性分子表示的复杂原子关系,DCGCN显著增强了DTI识别.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 生物信息学是一种生物信息学.
背景情况:
- 药物向相互作用 (DTI) 对于开发新疗法至关重要.
- 目前的DTI预测方法通常依赖于简化的分子表示,如SMILES或2D图形,这些图形忽略了关键的3D结构信息.
- 现有方法的局限性阻碍了对药物的有效性和潜在副作用的准确预测.
研究的目的:
- 开发一种先进的计算方法,通过结合三维 (3D) 分子结构来预测药物向相互作用 (DTI).
- 解决现有的DTI预测技术的局限性,这些技术主要使用1D或2D分子数据.
- 提高DTI预测的准确性和可靠性,以加速药物发现.
主要方法:
- 提出DCGCN,一种利用3D分子结构的DTI预测模型.
- 将3D点云数据分解成原子序列,连接性和距离地图.
- 使用双通道图形卷积网络 (GCN) 进行原子关系分析和1D卷积层用于序列信息提取.
主要成果:
- 与几种最先进的DTI预测方法相比,DCGCN在两个公共数据集上表现出更优异的性能.
- 该模型有效地利用3D结构信息捕捉了复杂的原子关系.
- 结果表明,通过结合3D分子数据,DTI识别准确度显著提高.
结论:
- 结合3D分子结构显著提高药物向相互作用预测.
- 在药物发现中,DCGCN为更准确和更有效的DTI识别提供了一个有前途的方法.
- 该研究强调了利用全面的分子结构数据在计算药物开发中的重要性.
更多相关视频
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
543
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
2.0K
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:30Quantitative Aspects of Drug-Receptor Interaction
1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
02:04Protein-protein Interfaces
13.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.5K
01:29Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
01:26Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
02:27Predicting Molecular Geometry
36.2K
VSEPR Theory for Determination of Electron Pair Geometries
36.2K